Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hongjin Xiaojie Capsule versus waiting list for breast pain
ISRCTN44184398Phase 4Completed
- Sponsor
- Yunnan Yousheng Pharmaceutical
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hongjin Xiaojie in mastalgia (2 arms), sponsored by Yunnan Yousheng Pharmaceutical. Primary endpoints: Breast pain severity and Duration of breast pain. Started Oct 2019; status: completed.
02
Drugs
Hongjin Xiaojie
03
Conditions
mastalgia
Beyond the preview
Go deeper on ISRCTN44184398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44184398.